Immunotherapy of superficial bladder cancer

A. Shapiro, D. Kadmon, W. J. Catalona, T. L. Ratliff

Research output: Contribution to journalReview articlepeer-review

25 Scopus citations


There is an increasing role for immunotherapy in the treatment of superficial recurrent bladder tumors and carcinoma in situ. BCG has proved to be an effective means of intravesical immunotherapy and a considerable experience with the treatment has accumulated. Other agents such as poly I:C, OK432 and transfer factor have not proved to be as effective. Interferon has shown impressive preliminary results but needs further evaluation in larger numbers of patients before definitive conclusions can be drawn.

Original languageEnglish (US)
Pages (from-to)891-894
Number of pages4
JournalJournal of Urology
Issue number5
StatePublished - Jan 1 1982

ASJC Scopus subject areas

  • Urology


Dive into the research topics of 'Immunotherapy of superficial bladder cancer'. Together they form a unique fingerprint.

Cite this